Oxycodone Pharmacokinetics and Pharmacodynamics in the Rat in the Presence of the P-Glycoprotein Inhibitor PSC833

This publication has 23 references indexed in Scilit:

• The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue
  Rapid Communications in Mass Spectrometry, 2004
• Effects of ABCB1 (multidrug resistance transporter) gene mutations on disposition and central nervous effects of loperamide in healthy volunteers
  Pharmacogenetics, 2003
• Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo
  Journal of Clinical Investigation, 2002
• A new multidrug resistance protein at the blood–brain barrier
  Biochemical and Biophysical Research Communications, 2002
• Interindividual Variability of the Clinical Pharmacokinetics of Methadone
  Clinical Pharmacokinetics, 2002
• Uptake and efflux of the peptidic delta-opioid receptor agonist [D-penicillamine2,5]-enkephalin at the murine blood–brain barrier by in situ perfusion
  Neuroscience Letters, 2001
• HumanMDR1and Mousemdr1aP-Glycoprotein Alter the Cellular Retention and Disposition of Erythromycin, but Not of Retinoic Acid or Benzo(a)pyrene
  Archives of Biochemistry and Biophysics, 1998
• Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.
  Journal of Clinical Investigation, 1997
• Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicine
  Life Sciences, 1997
• Antinociceptive Effects and Central Nervous System Depression Caused by Oxycodone and Morphine in Rats
  Basic & Clinical Pharmacology & Toxicology, 1992